IntegraGen SA provides sequencing solutions, data management tools, and biostatistical and bioinformatics support services to researchers in France. Its genomic pharma services include DNA sequencing for oncology and rare disease research, as well as NGS testing for cancer research. The company also offers MERCURY, an online biological interpretation tool for oncology that helps pathologists and oncologists turn raw high-throughput sequencing data into a molecular report for translational and clinical research; Galileo, a cloud-based app for dynamic exploration of RNA-Seq expression data; and GeCo, a genomic consulting service giving researchers access to biostatistics and bioanalytics experts. Incorporated in 2000 and headquartered in Évry, France, IntegraGen SA operates as a subsidiary of OncoDNA SA.